Better FDA Act of 2025
Download PDFSponsored by
Sen. Marshall, Roger [R-KS]
ID: M001198
Bill Summary
Another masterpiece of legislative theater, courtesy of the 119th Congress. Let's dissect this farce and expose its true intentions.
**Main Purpose & Objectives**
The Better FDA Act of 2025 is a cleverly crafted bill that purports to enhance food safety by requiring notifications to the Food and Drug Administration (FDA) regarding substances generally recognized as safe (GRAS). The real purpose, however, is to create a new regulatory framework that benefits certain industries at the expense of public health.
**Key Provisions & Changes to Existing Law**
The bill amends the Federal Food, Drug, and Cosmetic Act by introducing a new section (409A) that requires manufacturers to notify the FDA about GRAS substances. The notification process is designed to be cumbersome, allowing the FDA to delay or reject applications at its discretion. This creates an opportunity for regulatory capture, where industries with deep pockets can influence the FDA's decisions.
The bill also redefines what constitutes a GRAS substance, making it easier for manufacturers to introduce new ingredients without thorough safety testing. This is a classic case of "regulatory relaxation," where the government appears to be strengthening regulations while actually weakening them.
**Affected Parties & Stakeholders**
The main beneficiaries of this bill are large food and chemical companies that can afford to navigate the complex regulatory landscape. These industries will enjoy reduced liability and increased flexibility in introducing new products, all while maintaining a veneer of safety.
On the other hand, small businesses, consumers, and public health advocates will be negatively impacted by this bill. The increased regulatory burden will stifle innovation among smaller companies, while the lack of transparency and accountability will put consumers at risk.
**Potential Impact & Implications**
The Better FDA Act of 2025 is a recipe for disaster. By allowing industries to self-regulate and introducing new substances without adequate safety testing, we can expect an increase in foodborne illnesses and environmental pollution.
This bill also sets a disturbing precedent for regulatory capture, where the interests of corporations are prioritized over public health. The FDA's ability to protect consumers will be compromised, and the agency will become even more beholden to industry lobbyists.
In conclusion, the Better FDA Act of 2025 is a masterclass in legislative deception. Behind its innocuous title and seemingly benevolent objectives lies a cynical attempt to undermine public health and safety. As with most congressional bills, this one requires a healthy dose of skepticism and a strong stomach to navigate its Byzantine provisions.
Related Topics
Sponsor's Campaign Donors
Showing top 5 donors by contribution amount
Donor Relationship Network
Interactive visualization showing donor connections. Click and drag nodes to explore relationships.
Showing 9 nodes and 0 connections
Cosponsor Donors
Top donors to cosponsors of this bill
Unknown
Unknown